GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Audientes AS (XSAT:AUDNTS) » Definitions » Debt-to-EBITDA

Audientes AS (XSAT:AUDNTS) Debt-to-EBITDA : -0.73 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Audientes AS Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Audientes AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr4.73 Mil. Audientes AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.00 Mil. Audientes AS's annualized EBITDA for the quarter that ended in Dec. 2023 was kr-6.45 Mil. Audientes AS's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.73.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Audientes AS's Debt-to-EBITDA or its related term are showing as below:

XSAT:AUDNTS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.58   Med: -0.16   Max: 0
Current: -0.58

XSAT:AUDNTS's Debt-to-EBITDA is ranked worse than
100% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs XSAT:AUDNTS: -0.58

Audientes AS Debt-to-EBITDA Historical Data

The historical data trend for Audientes AS's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Audientes AS Debt-to-EBITDA Chart

Audientes AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial - - - -0.32 -0.58

Audientes AS Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 -0.53 -0.85 -0.67 -0.73

Competitive Comparison of Audientes AS's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Audientes AS's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Audientes AS's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Audientes AS's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Audientes AS's Debt-to-EBITDA falls into.



Audientes AS Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Audientes AS's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.726 + 0) / -8.133
=-0.58

Audientes AS's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.726 + 0) / -6.448
=-0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Audientes AS  (XSAT:AUDNTS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Audientes AS Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Audientes AS's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Audientes AS (XSAT:AUDNTS) Business Description

Traded in Other Exchanges
N/A
Address
Teknikerbyen 5, Virum, DNK, 2830
Audientes AS is a technology company specializing in smart, self-fitting, and affordable hearing aids. Audientes' hearing aid solution ''Ven'', is available for purchase in the Indian market, online, and in retail, and will be introduced to the U.S over-the-counter market and other markets. The company's mission is to help the approximately 500 million people globally suffering from disabling hearing loss who either cannot afford to buy one of the very expensive hearing aids on the market.

Audientes AS (XSAT:AUDNTS) Headlines

No Headlines